At Astellas, a commitment to creating a brighter future is the foundation of everything we do.
Our vision is to change tomorrow. To improve the lives of men, women and children by providing innovative medicines in areas of health where there is urgent need for better treatments. Transplant recipients, patients fighting cancer, those with life-threatening infections – these are just some of the patients we are striving to help now and in the future through a single-minded focus on research and development in areas of high unmet medical need.
CHANGING TOMORROW™ is the ethos that guides everything that Astellas does, and is the measure by which we judge our success.
Contact
Astellas Pharma S.p.A.
P.I 00789580966 – C.F. 04754860155
L’indirizzo della Sede Astellas è:
Via del Bosco Rinnovato, 6 – Edificio U7
20090 Assago (MI)
Tel.: +39 02 921381
Francesco Carugi, Managing Director at Grifols Italy, discusses the company’s presence in the plasma, plasma products and plasma diagnostics segments, the impact of the liberalization of the Italian plasma market on…
Dr. Giorgio Pisani, President and CEO of IBSA Italy, talks about his founding of the company in 2001 and its rapid growth in the market through a combination of organic…
Prof. Walter Ricciardi has just been appointed as the new president for the Italian National Institute of Health (ISS). He explains his priorities since taking office, the crucial role the…
Paolo Casati, general manager for Santen’s new affiliate in Italy, discusses the company’s first full year in the country, its aims for contributing to the global group’s 2020 Vision by…
Paolo Cionini, General Manager of LEO Pharma Italy, discusses the initial challenges of setting up the Italian affiliate during the height of the global financial crisis in 2011, the company’s…
Sofia Astrid Pennacchi, Secretary General of the British Chamber of Commerce for Italy, discusses the various services the Chamber offers its members, the positive effects the Expo has had on…
Giulio Volpe, Managing Director of Lundbeck’s Italian API’s production plant, discusses what is leading multinational companies to relocate their production to Italy, the value the Italian plant can offer the…
Enrico Allievi, President of the Italian OTC (Over The Counter) association, Assosalute, talks about the state of the OTC market in Italy, as well as the association’s role in creating…
Dr. Anna Maria Porrini, President of Boehringer Ingelheim Italy shares her vision for the company, how she intends to achieve it and where she sees opportunities for the company’s success…
Antonino Reale, who has managed Daiichi-Sankyo Italy for the last 12 years, explains the reasoning and strategy behind the company’s almost total restructuring in 2013, including how this has given…
Gabriele Baccelli shares his journey of setting up a lean organization at a time of crisis, the management decisions he took in order to navigate this environment and how he…
The Italian Medicines Agency, AIFA, sits at a crossroads. Its Director-General Prof. Luca Pani discusses the apparent contradiction in the agency’s mission at a time of constricting budgets and expensive…
See our Cookie Privacy Policy Here
